Public Display Solicitation
You must Log in with your eHawaii Account to respond to a solicitation.
B26002727 FENTANYL DETECTION, EARLY INTERVENTION - 12 PANEL DRUG TEST KIT
- Solicitation Number
- B26002727
- Status
- Released
- Department
- Corrections and Rehabilitation
- Division
- Hawaii Paroling Authority
- Islands (where the work/delivery is to be performed)
- Hawaii, Kauai, Maui, Oahu
- Category
- Goods and Services
- Release Date
- 05/11/2026
- Offer Due Date & Time
- 06/03/2026 04:30 PM
- Description
- The Hawaii Paroling Authority (HPA) is requesting competitive sealed bids from qualified vendors to establish a Statewide price list contract for the purchase and delivery of integrated urine-based 12-panel drug testing kits with fentanyl detection capabilities.
The testing kits will support HPA’s Statewide supervision, clinical monitoring, treatment compliance, abstinence verification, early intervention, and relapse detection efforts for supervised individuals under HPA jurisdiction. Proposed products shall meet clinical monitoring standards and demonstrate high analytical sensitivity for the detection of low concentrations of controlled substances, including fentanyl.
The solicitation requires integrated 12-panel drug testing kits capable of detecting the following analytes: THC, Buprenorphine, Benzodiazepines, Methadone, Amphetamines, Oxycodone, Opiates, MDMA/Ecstasy, Cocaine, Methamphetamine, Alcohol (EtG), and Fentanyl.
Estimated annual usage is approximately 6,000 kits Statewide. Deliveries will be ordered on an as-needed basis and distributed to HPA offices located on Oahu, Hawaiʻi Island, Maui, and Kauaʻi.
The resulting contract term shall be from July 1, 2026 through June 30, 2027, with the option to extend for up to three (3) additional twelve (12)-month periods, subject to satisfactory contractor performance, continued operational need, and availability of funds.
All proposals, questions, and solicitation communications shall be submitted electronically through HIePRO in accordance with the solicitation requirements and deadlines. - Contact Person
- Yamamoto, Marc
- dcr.bids@hawaii.gov
- Phone
- 808-587-3464
- General Comments
- This solicitation is issued by the Hawaii Paroling Authority (HPA) to establish a price list contract for integrated urine-based 12-panel drug testing kits with fentanyl detection capabilities.
Offerors shall carefully review all solicitation documents, specifications, requirements, and attachments prior to submitting a bid.
All bids, questions, requests for clarification, and communications regarding this solicitation shall be submitted electronically through HIePRO only. Verbal communications shall not be binding.
Offerors are strongly encouraged to register as an “Interested Vendor” within HIePRO to receive notifications regarding amendments, addenda, questions and answers, and other procurement updates.
Questions regarding this solicitation must be submitted by the stated deadline identified in the solicitation. Responses to substantive questions and any solicitation addenda will be issued through HIePRO.
Offerors are responsible for monitoring HIePRO for all official procurement communications, addenda, and updates. Failure to review issued addenda shall not relieve the Offeror from compliance with solicitation requirements.
Late submissions may not be accepted.
The State reserves the right to reject any or all bids, waive minor informalities, request additional information, conduct discussions, request Best and Final Offers (BAFO), and/or cancel this solicitation if determined to be in the best interest of the State.
Award, if made, shall be issued to the responsive and responsible bidder whose proposal is determined to be most advantageous to the State in accordance with the solicitation requirements and evaluation criteria.
All applicable State procurement laws, administrative rules, and compliance requirements shall apply. - Procurement Officer
- Earl Everett
- Attachments
-
HPA Fentanyl Detection Early Intervention-HPA Competitive Seal Bid IFB No 26002727.pdf
AG-008 103D General Conditions (1.10.23).pdf
Download All
Direct all questions regarding this Solicitation, and any questions or Issues relating to the accessibility of this Solicitation (Including the appendices and exhibits to this Document, and any other document related to this Solicitation), to: Yamamoto, Marc.
B26002727 FENTANYL DETECTION, EARLY INTERVENTION - 12 PANEL DRUG TEST KIT
#
Title
Quantity
Unit of Measure
Commodity Code
| Commodity Code | Description |
|---|---|
| 325413 | In-vitro diagnostic substances manufacturing |
| 325413 | Diagnostic substances, in-vitro, manufacturing |
- Quantity
- 1
- Unit of Measure
- CASE
- Title
- Drug Test Kits (12-Panel) with Fentanyl
- Description
- One (1) case, also referred to as one (1) kit, shall contain one hundred (100) individually packaged 12-panel urine drug testing cups. Each cup shall be an integrated, multi-panel screening device capable of detecting the required substances as specified in the solicitation, including fentanyl. Test cups shall be intended for single-use clinical screening and shall meet all applicable performance, regulatory, and sensitivity requirements outlined in the IFB.
Direct all questions regarding this Solicitation, and any questions or Issues relating to the accessibility of this Solicitation (Including the appendices and exhibits to this Document, and any other document related to this Solicitation), to: Yamamoto, Marc.